Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks*

Drexel University College of Medicine, Philadelphia

George Washington University Medical Center, Washington D.C.

Whitman-Walker Clinic, Washington D.C.

UNC at Chapel Hill, Chapel Hill

AIDS Research Consortium of Atlanta, Inc., Atlanta

Orlando Immunology Center, Orlando

Gary Richmond, Fort Lauderdale

Ohio State University Medical Center, Columbus

University Hospitals of Cleveland, Cleveland

Northwestern University Feinberg School of Medicine, Chicago

Southwest Infectious Diseases, Dallas

Central Texas Clinical Research, Austin

University of Colorado Health Science Center, Denver

UCLA Medical Center, Los Angeles

Quest Clinical Research, San Francisco

The Research Insitute, Boston

Miriam Hospital/Brown University, Providence

University of Texas Medical Branch Internal Medicine, Galveston